价格

19-3-19

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

显示相关度最高的 100 个专利族。

19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF
US 2016108080 A1申请人: SAGE THERAPEUTICS INC优先权: 2013
CN
US
12 件公开
A CRYSTALLINE 19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID
EP 3504189 A1申请人: SAGE THERAPEUTICS INC优先权: 2016
CN
EP
WO
7 件公开
3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF
EP 2766380 B1申请人: SAGE THERAPEUTICS INC优先权: 2011
CN
EP
US
6 件公开
Contraception method using competitive progesterone antagonists and novel compounds useful therein
US 7297702 B2申请人: SCHERING AG优先权: 2001
US
6 件公开
COMPOUNDS, COMPOSITIONS, KITS AND METHODS OF USE TO ORALLY AND TOPICALLY TREAT ACNE AND OTHER SKIN CONDITIONS BY ADMINISTERING A 19-NOR CONTAINING VITAMIN D ANALOG WITH OR WITHOUT A RETINOID
US 2008261925 A1申请人: CLAGETT-DAME MARGARET优先权: 2007
US
5 件公开
USE OF COLLAGEN-POLYVINYLPYRROLIDONE IN PULMONARY INFLAMMATION AND FIBROSIS IN PATIENTS INFECTED BY THE SARS-COV2 VIRUS (COVID-19)
US 2023285516 A1申请人: ASPID S A DE C V优先权: 2020
CN
EP
US
WO
4 件公开
Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
US 7772218 B2申请人: STANFORD RES INST INT优先权: 2001
US
4 件公开
Crystalline forms of 11-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17-pregna-4,9-dien-3-one
US 7910573 B2申请人: BAYER SCHERING PHARMA AG优先权: 2006
EP
US
3 件公开
18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same
US 7846917 B2申请人: BAYER SCHERING PHARMA AG优先权: 2006
CN
US
3 件公开
C-19 steroids for specific therapeutic uses
US 10265328 B2申请人: WINDISCH MARTIN优先权: 2007
EP
US
3 件公开

药物